ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SPRC SciSparc Ltd

2.49
0.06 (2.47%)
Pre Market
Last Updated: 04:37:02
Delayed by 15 minutes

Period:

Draw Mode:

Volume 655
Bid Price 2.45
Ask Price 2.49
News -
Day High

Low
2.26

52 Week Range

High
23.66

Day Low
Company Name Stock Ticker Symbol Market Type
SciSparc Ltd SPRC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.06 2.47% 2.49 04:37:02
Open Price Low Price High Price Close Price Prev Close
2.43
Trades Volume Avg Volume 52 Week Range
9 655 - 2.26 - 23.66
Last Trade Time Type Quantity Stock Price Currency
04:36:06 formt 200 $ 2.49 USD

SciSparc Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.27M 521.09k - 1.35M -2.59M -4.97 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

SciSparc News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SPRC Message Board. Create One! See More Posts on SPRC Message Board See More Message Board Posts

Historical SPRC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.163.162.262.78618,026-0.67-21.20%
1 Month6.456.782.263.751,293,175-3.96-61.40%
3 Months5.046.782.265.031,064,575-2.55-50.60%
6 Months3.897414.21992.265.753,171,524-1.41-36.11%
1 Year14.8223.662.266.391,864,646-12.33-83.20%
3 Years182.00184.082.2619.771,541,122-179.51-98.63%
5 Years182.00184.082.2619.771,541,122-179.51-98.63%

SciSparc Description

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company operates in the single segment of the Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority.

Your Recent History

Delayed Upgrade Clock